Looking to #invest in #Biotech? #BioMarkDiagnostics is a leader in next-gen #cancer diagnostics using #metabolites. We are developing proprietary, non-invasive, highly accurate solutions to cost-effectively detect cancer in the very early stages when most cancers can be cured.

Lung Foundation says federal government must implement cancer screening to save 12,000 lives https://t.co/e41skQWV1h

Asbestos has been banned in many countries around the world. Moreover, if you smoke cigarettes and are exposed to asbestos fibres, the risk of lung cancer developing is 50-90 times greater than if you are a non-smoker who was also exposed to asbestos.

#Asbestos In the past, asbestos fibres were used in thermal heating and acoustic insulation methods in homes and workplaces. Since the discovery that the silicate fibres in asbestos can lead to a lifetime of lung damage and #lungcancers.

New antibody therapy for children with medulloblastoma has shown promise during a Phase I clinical trial. The antibody, which targets a protein that enables #cancer cells to multiply and spread, was well tolerated & helped to stabilize the disease.

Relapsed and refractory tumors are especially challenging after the standard treatments of surgery, radiation, and chemotherapy have failed.

Medulloblastoma is the most common type of brain cancer in children. These tumors are known to be aggressive growing quickly and has the potential to metastasize to other areas of the body. https://t.co/xh4dfG2rGG

Key Players @NovartisOncology Switzerland @Quidel @RANDOXLABORATORIES @TrivitronHealthcare @JohnsonandJohnson @Abbott @SiemensHealthcare Pvt. Ltd. @BioRadLaboratories, @DanaherCorporation @BiomarkDx #cardiology #medicine #novartis #healthcare #health #hearthealth #mrfr

#cardiac #biomarkers market is expected to register a CAGR of 16.36% during the forecast period and is expected to hit USD 4236.02 Million by 2027. More Details@ https://t.co/omOeU9GhjV

(BioMark’s assay advantages include low cost, minimally invasive, low false positives and leverages existing lab infrastructure) https://t.co/mypouOX3Sz

Lung Cancer Metabolite Panel – Early detection of lung cancer in #highriskpopulations and complement Low dose CT screening for lung cancer. Below is an abstract* that provides a potential market impact of our diagnostic test success for this application.

The Company’s initial focus beyond a general cancer red alert tool is on diagnostics for lung cancer, with plans to expand into breast, pancreatic, thyroid, and glioblastoma cancers. CSE Symbol: BUX | FSE Symbol: 20B | OTCMKTS Symbol: BMKDF

BioMark is also developing diagnostics that can be used to increase the uptake of lung cancer screening using Low Dose CT, measuring a patient’s response to treatment, and for the ongoing monitoring of cancer survivors.

(EBUS) will be done to remove a piece of tissue from a node or tumor. If necessary, surgeons may remove a tissue sample. If so, a pathologist will examine the tissue to determine whether cancer is present and, if so, the type and stage of cancer.

How do doctors diagnose lung cancer? When lung cancer is suspected, patients typically have a CT scan, MRI, or PET/CT scan to produce a detailed image of their lungs. If a mass is detected, either a fine needle biopsy, core needle biopsy, bronchoscopy or endobronchial ultrasound.

Patients with mesothelioma may notice lumps, pain, or swelling in their abdomen or pain under the rib cage.

What are the symptoms of lung cancer? More common symptoms include a cough that does not go away, trouble breathing, chest discomfort, wheezing, hoarseness, and streaks of blood in the mucus. Loss of appetite, weight loss for no reason, and unusual tiredness.

What are the risk factors for lung cancer? 1) 90 % of lung cancers are caused by cigarette smoke. 2) Exposure to second-hand smoke 3) Radiation therapy 4) Exposure to asbestos, radon, chromium, nickel, arsenic, soot, or tar. 5) Air pollution 6) Family history of lung cancer

Mesothelioma — Although it is not technically a lung cancer, mesothelioma shares many of the same symptoms as lung cancer. Malignant mesothelioma is a disease in which cancer cells form in the linings of the organs, most often the pleura and sometimes the peritoneum.

Small cell lung cancer — Small cell lung cancer also is named for the size of the cells when viewed under a microscope. Affecting approximately 15 percent of lung cancer patients, it typically starts in the bronchial passages.